Animal models of Epstein Barr virus infection.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Opinion in Virology

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.coviro.2015.03.014PMID 25846986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infectious mononucleosis.

  2024cited by this paper
• LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

  2015cited by this paper
• Gammaherpesviruses and lymphoproliferative disorders.

  2014cited by this paper
• Dendritic Cell–Mediated Immune Humanization of Mice: Implications for Allogeneic and Xenogeneic Stem Cell Transplantation

  2014cited by this paper
• Adoptive Transfer of EBV Specific CD8+ T Cell Clones Can Transiently Control EBV Infection in Humanized Mice

  2014cited by this paper
• T Cells Modulate Epstein-Barr Virus Latency Phenotypes during Infection of Humanized Mice

  2014cited by this paper
• Role for early-differentiated natural killer cells in infectious mononucleosis.

  2014cited by this paper
• Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory.

  2014cited by this paper
• Animal models of Epstein Barr virus infection.

  2014cited by this paper
• FLT3-Ligand Treatment of Humanized Mice Results in the Generation of Large Numbers of CD141+ and CD1c+ Dendritic Cells In Vivo

  2014cited by this paper
• Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas.

  2013cited by this paper
• CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice.

  2013cited by this paper
• EBV stimulates TLR‐ and autophagy‐dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape

  2013cited by this paper
• The pathogenesis of Epstein-Barr virus persistent infection.

  2013cited by this paper
• Cryptopatches are essential for the development of human GALT.

  2013cited by this paper
• Innate immune responses against Epstein Barr virus infection

  2013cited by this paper
• Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection.

  2013cited by this paper
• BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression

  2012cited by this paper
• EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.

  2012cited by this paper
• Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells.

  2011cited by this paper
• Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence.

  2010cited by this paper
• Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice

  2010cited by this paper
• A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas

  2010cited by this paper
• TLR9 Contributes to the Recognition of EBV by Primary Monocytes and Plasmacytoid Dendritic Cells

  2010cited by this paper
• Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection

  2010cited by this paper
• Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3

  2009cited by this paper
• Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

  2009cited by this paper
• T cell-mediated control of Epstein-Barr virus infection in humanized mice.

  2009cited by this paper
• A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses.

  2008cited by this paper
• CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection.

  2008cited by this paper
• The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways.

  2007cited by this paper
• Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice.

  2007cited by this paper
• Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

  2006cited by this paper
• The immune response to primary EBV infection: a role for natural killer cells

  2005cited by this paper
• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice

  2005cited by this paper
• Post-transplant lymphoproliferative disorders.

  2005cited by this paper
• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

  2005cited by this paper
• Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12

  2004cited by this paper
• Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice

  2004cited by this paper
• Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro

  2003cited by this paper
• Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells

  2002cited by this paper
• Generation of EBV-Specific CD4+ Cytotoxic T Cells from Virus Naive Individuals1

  2002cited by this paper
• Severe herpesvirus infections in an adolescent without natural killer cells.

  1989cited by this paper
• Regulation of Epstein‐Barr virus infection by recombinant interferons. Selected sensitivity to interferon‐γ

  1985cited by this paper
• Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis.

  1984cited by this paper
• Activation of latent Epstein–Barr virus by antibody to human IgM

  1978cited by this paper
• COMPARISON OF THE YIELD OF INFECTIOUS VIRUS FROM CLONES OF HUMAN AND SIMIAN LYMPHOBLASTOID LINES TRANSFORMED BY EPSTEIN-BARR VIRUS

  1973cited by this paper
• MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

  1965cited by this paper
• VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

  1964cited by this paper
• The transmission of infectious mononucleosis.

  1955cited by this paper
• The transmission of infectious mononucleosis.

  1955cited by this paper

• Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization.

  2025cites this paper
• Epstein–Barr virus in thyroid disease: an integrated immunovirological perspective

  2025cites this paper
• Unveiling the Immune Landscape: Single‐Cell Sequencing of Infectious Mononucleosis Patients

  2025cites this paper
• Chromosome‐level Asian elephant genome assembly and comparative genomics of long‐lived mammals reveal the common substitutions for cancer resistance

  2023cites this paper
• Chronic Epstein-Barr virus infection: A potential junction between primary Sjögren's syndrome and lymphoma.

  2023cites this paper
• MHC class II‐deficient mice allow functional human CD4+ T‐cell development

  2023cites this paper
• Tree Shrew Is a Suitable Animal Model for the Study of Epstein Barr Virus

  2022cites this paper
• Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection

  2021cites this paper
• Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region

  2021cites this paper
• Uncovering early events in primary Epstein-Barr virus infection using a rabbit model

  2021cites this paper
• The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development

  2021cites this paper
• Dangerous Liaisons: Gammaherpesvirus Subversion of the Immunoglobulin Repertoire

  2020cites this paper
• Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15

  2020cites this paper
• Rhesus macaque rhadinovirus R12 is required for promyelocytic leukemia nuclear body disruption and inhibits innate immune responses

  2018cites this paper
• Macaca arctoides gammaherpesvirus 1 (strain herpesvirus Macaca arctoides): virus sequence, phylogeny and characterisation of virus-transformed macaque and rabbit cell lines

  2018cites this paper
• EBV persistence without its EBNA3A and 3C oncogenes in vivo

  2018cites this paper
• Humanized Mouse Models of Clinical Disease.

  2017cites this paper
• Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus

  2017cites this paper
• Dynamics of Sendai Virus Spread, Clearance, and Immunotherapeutic Efficacy after Hematopoietic Cell Transplant Imaged Noninvasively in Mice

  2017cites this paper
• The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses.

  2017cites this paper
• HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach.

  2016cites this paper
• Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis

  2016cites this paper
• Immunity to Oncogenic Viruses

  2016cites this paper
• Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice

  2015cites this paper
• EBER RNAs give higher LMP 2 RNA expression in 1 lymphoblastoid cell lines and efficiently establish persistent infection in humanized mice 2 3

  2015cites this paper
• The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events

  2015cites this paper